Sign In
Buy CFMS
$2.26
+0 (+0%)
At Close: Nov 30, 2023
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Monday, 06'th Mar 2023
ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Conformis, Inc. (CFMS) Q4 2022 Earnings Call Transcript
09:49pm, Wednesday, 01'st Mar 2023
Conformis, Inc. (NASDAQ:CFMS ) Q4 2022 Results Conference Call March 1, 2023 4:30 PM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - CFO and Treasurer Conferenc
Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results
04:05pm, Wednesday, 01'st Mar 2023
BILLERICA, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today fi
Conformis, Inc. to Participate in Upcoming Investor Conferences
04:15pm, Tuesday, 21'st Feb 2023
BILLERICA, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today th
Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation
04:15pm, Wednesday, 15'th Feb 2023
Conformis and Bodycad Settle Litigation Related to Bodycad's Patient-Specific Instruments and Implants Conformis and Bodycad Settle Litigation Related to Bodycad's Patient-Specific Instruments and Imp
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
04:30pm, Monday, 23'rd Jan 2023
BILLERICA, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it wi
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
12:38pm, Friday, 25'th Nov 2022 Benzinga
Gainers
VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).
Cosmos Hol
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
10:25am, Wednesday, 23'rd Nov 2022 Benzinga
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
08:49am, Tuesday, 22'nd Nov 2022 Benzinga
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
NeuroOne Medical Techn
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
06:36pm, Monday, 21'st Nov 2022 Benzinga
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Nexalin Technology, Inc. (NASDAQ: NXL) jumpe
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
10:58am, Monday, 21'st Nov 2022 Benzinga
Gainers
AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.
FOXO Technologies Inc. (NYSE: FOXO) shares surged 46.9% to close at $0.6520 on Friday. Foxo Technologies re
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
06:15pm, Friday, 18'th Nov 2022 Benzinga
Gainers
PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
Satixfy Communications Ltd. (N
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
10:14am, Friday, 18'th Nov 2022 Benzinga
Gainers
Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Elevate Credit, Inc. (NYSE: ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company ag
Conformis Announces Full Commercial Launch of Imprint™
12:00pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) Conformis’ Imprint™ knee system introduces the new “Made-to
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
09:15pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Conformis Settles Medacta Litigation Related to Patient-Specific Instruments Conformis Settles Medacta Litigation Related to Patient-Specific Instruments
